Drug Trial Radar · NCT04923347
A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Last checked: Nov 20, 2026Latest source record: Mar 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
229
Actual
Start
Jun 6, 2023
Primary completion
Mar 14, 2024
Study completion Mar 14, 2024
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Jun 11, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate safety and efficacy of FF/UMEC/VI via ELLIPTA® inhaler. ELLIPTA is a registered trademark of GlaxoSmithKline group of companies.
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
FF/UMEC/VIDrug
FF/UMEC/VI will be administered
ELLIPTADevice
Participants will receive FF/UMEC/VI using ELLIPTA inhaler.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Adverse Events (AE), Serious Adverse Events (SAE) and Adverse Events of Special Interest (AESIs)Time frame: Up to approximately 40 weeks
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
GSK Investigational Site
Ajmer, India
GSK Investigational Site
Bangalore, India
GSK Investigational Site
Bikaner, India
GSK Investigational Site
Hyderabad, India
GSK Investigational Site
Jaipur, India
GSK Investigational Site
Kolkata, India
GSK Investigational Site
Kolkata, India
GSK Investigational Site
Kozhikode, India
GSK Investigational Site
Mumbai, India
GSK Investigational Site
Mysore, India
GSK Investigational Site
Nagpur, India
GSK Investigational Site
Nashik, India
GSK Investigational Site
Pondy-Cuddalore ECR Main Road Pillaiyarkuppam Pond, India
GSK Investigational Site
Pune, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.